Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04636190 · ClinicalTrials.gov registry record · NA
Triathlon All-Polyethylene Tibia Outcomes Study
A NA study of Knee Arthritis and Arthropathy of Knee, sponsored by Stryker Orthopaedics.
- Active
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 6
- Study locations
NCT04636190: Active NA study of Knee Arthritis and Arthropathy of Knee, sponsored by Stryker Orthopaedics.
NCT04636190 is a NA study of Knee Arthritis and Arthropathy of Knee that is active but no longer recruiting, run by Stryker Orthopaedics. The registered enrollment target is 204 participants, above the 112-participant average among 7 other Knee Arthritis trials with a reported enrollment target (82% higher). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04636190, a NA study of Knee Arthritis and Arthropathy of Knee, is active but no longer recruiting, sponsored by Stryker Orthopaedics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to evaluate the clinical functional results of the Triathlon All-Polyethylene Tibia Knee Device.
Primary Outcome
The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome postoperative.
Conditions Studied
Interventions
- DEVICE Triathlon All-Polyethylene Tibia Knee
Study Locations (6)
New York
- Kaleida Health, Department of Orthopaedic Surgery, Buffalo General Hospital - Buffalo
- Syracuse Orthopedic Specialists, PC - Syracuse
Michigan
- Michigan Orthopaedic Center - Lansing
North Carolina
- Duke University Medical Center - Durham
Ohio
- Department of Orthopaedic Surgery Cleveland Clinic - Cleveland
Texas
- Musculoskeletal Institute, University of Texas Health Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2021-07-02 |
| Est. Completion | 2033-10 |
| Phase | NA |
What the registry record for NCT04636190 still lists
NCT04636190 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, above the 112-participant average among 7 other Knee Arthritis trials with a reported enrollment target (82% higher).
The record links to 3 conditions, with Knee Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Triathlon All-Polyethylene Tibia Knee is the first listed.
NCT04636190 lists 6 locations in 5 states (New York, Michigan, North Carolina).
Frequently Asked Questions
What is clinical trial NCT04636190 about?
NCT04636190 is a clinical study titled "Triathlon All-Polyethylene Tibia Outcomes Study". The purpose of this study is to evaluate the clinical functional results of the Triathlon All-Polyethylene Tibia Knee Device.
What is the current status of trial NCT04636190?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2021-07-02. Estimated completion is 2033-10.
What conditions does trial NCT04636190 study?
This clinical trial studies the following conditions: Knee Arthritis, Arthropathy of Knee, Replacement.
What interventions are being tested in trial NCT04636190?
The interventions under investigation include: Triathlon All-Polyethylene Tibia Knee (DEVICE).
Who is sponsoring clinical trial NCT04636190?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04636190 being conducted?
This trial has 6 study locations across Michigan, New York, North Carolina, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blood-Flow Restriction Exercise Following a Knee Replacement
ACTIVE NOT RECRUITING · NA
-
Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain
ACTIVE NOT RECRUITING · NA
-
Preoperative Pain Threshold and Rapid Recover Programs
COMPLETED · NA
-
Gold Factor on Knee Joint Health and Function
COMPLETED · NA
-
Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis
RECRUITING · Phase 2
-
Performance of MOTO Medial® Unicompartmental Knee Arthroplasty
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI